Enoxaparin Sodium
Product Images NDC 68001-463

Product Visual Gallery

This gallery contains 41 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 68001-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Instructions 1 (Enoxaparin 00)

An instructional illustration showing the correct and incorrect technique for handling a prefilled syringe of Enoxaparin Sodium injection. The left panel demonstrates holding the syringe properly with fingers away from the plunger, while the right panel shows a crossed-out example of improper finger placement on the plunger.*

FDA Label Image

Instructions 2 (Enoxaparin 01)

An instructional illustration showing two hands preparing a syringe for injection. One hand holds the syringe barrel with a thumb pressing the plunger, and arrows indicate the motion of the plunger being pushed and pulled. This image is likely part of an administration or usage guide for Enoxaparin Sodium injection.*

FDA Label Image

Instructions 3 (Enoxaparin 02)

An instructional line drawing showing how to use a safety syringe with activation prongs. The image highlights a hand holding the syringe and includes a caution not to touch the safety device activation prongs, indicating proper handling technique.*

FDA Label Image

Instructions 4 (Enoxaparin 03)

An instructional illustration depicting a hand holding a vial or syringe near an injection site on a person's arm, demonstrating the technique for subcutaneous administration. This image relates to the Enoxaparin Sodium injection, used for subcutaneous delivery.*

FDA Label Image

Instructions 5 (Enoxaparin 04)

An instructional illustration showing a hand pulling back a sleeve to expose the forearm, likely demonstrating preparation or administration of a subcutaneous injection.*

FDA Label Image

Instructions 6 (Enoxaparin 05)

An instructional illustration showing a hand holding a syringe-like device aimed to insert or remove something from a rectangular container with a hinged lid. The image appears to demonstrate proper handling or usage technique for a medical or pharmaceutical product, possibly related to injection or sample preparation.*

FDA Label Image

Chemical Structure (Enoxaparin 06)

Chemical structure diagram of enoxaparin sodium, depicting the molecular arrangement of its polysaccharide chains with associated functional groups, as relevant to the active ingredient in Enoxaparin Sodium injection by BluePoint Laboratories.*

FDA Label Image

Chemical Structure (Enoxaparin 07)

Chemical structure of enoxaparin sodium, depicting the molecular arrangement relevant to the active ingredient in the Enoxaparin Sodium injection by BluePoint Laboratories.*

FDA Label Image

Figure 1 (Enoxaparin 08)

A forest plot displaying relative risk comparisons between enoxaparin sodium and unfractionated heparin (UFH) across multiple patient subgroups, including sex, age, infarct location, diabetes history, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI status. The plot includes numerical values for UFH and enoxaparin percentages plus risk reduction, with a reference line at relative risk 1.0 indicating enoxaparin’s comparative effectiveness.*

FDA Label Image

Figure 2 (Enoxaparin 09)

A survival curve chart comparing the heart attack or death rates over 30 days between Enoxaparin and UFH treatments. The x-axis represents time in days, and the y-axis shows the hazard of death or heart attack. An inset graph depicts similar survival data over one year with corresponding statistical test results.*

FDA Label Image

Diagram, Engineering Drawingdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 14)

Illustration showing the components and states of a prefilled injection syringe before and after use. The labeled parts include the plunger rod, needle with needle cover before use, and the protective sleeve after use. This diagram demonstrates proper handling of the syringe for subcutaneous injection.*

FDA Label Image

Diagramdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 13)

An instructional illustration showing components for administering Enoxaparin Sodium Injection subcutaneously. It includes an enoxaparin sodium injection syringe, a sharps disposal container, one cotton ball or gauze, one alcohol wipe, and one small adhesive bandage, all labeled accordingly.*

FDA Label Image

Diagramdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 12)

An instructional illustration showing a hand holding a prefilled syringe containing Enoxaparin Sodium injection, positioned within a molded tray. The syringe is being held around the barrel, showing proper hand placement for administration by subcutaneous injection.*

FDA Label Image

Diagramdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 11)

An illustration showing a labeled injection syringe with a plunger on the right and needle on the left. The label points to the area near the syringe barrel where the expiration date can be found. The syringe is empty and presented in a side view.*

FDA Label Image

Diagramdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 10)

Illustration of a syringe filled with a clear liquid, labeled as Enoxaparin Sodium injection. The diagram highlights the clear liquid inside the syringe, used for subcutaneous administration.*

FDA Label Image

Shapedescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 09)

Illustration depicting the injection site areas recommended for subcutaneous administration of medication in the abdominal region. The areas are shaded rectangles on the left and right sides of the abdomen, avoiding the central area around the navel.*

FDA Label Image

A Picture Containing Arrowdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 08)

Illustration showing a hand holding a small square applicator or swab, pressing it against the lower abdomen of a person, likely depicting the method to prepare or clean the injection site for subcutaneous injection.*

FDA Label Image

Diagramdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 07)

An instructional illustration showing two hands handling a syringe injection device. One hand holds the syringe barrel while the other hand is pulling or pushing the needle cap with arrows indicating removal or attachment direction. The image suggests proper technique for preparing the syringe for subcutaneous injection.*

FDA Label Image

Diagramdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 06)

An instructional line drawing showing a hand adjusting a prefilled syringe with a dose-setting mechanism. The visual demonstrates how to set the dose by turning or sliding a part of the syringe, indicated by a large downward arrow and the text "Set your dose" next to the syringe.*

FDA Label Image

Shapedescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 05)

Illustration showing a hand pinching the skin on an abdomen, demonstrating a technique for subcutaneous injection administration.*

FDA Label Image

Diagramdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 04)

Instructional illustration showing a hand administering a subcutaneous injection using a syringe. The syringe is positioned at a 90-degree angle to the skin, with an arrow indicating the injection direction. The image demonstrates proper injection technique, likely for Enoxaparin Sodium injection.*

FDA Label Image

A Picture Containing Textdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 03)

An instructional illustration showing the administration of Enoxaparin Sodium injection by subcutaneous injection into the abdominal area. The image depicts a hand holding the syringe at a right angle to the skin, indicating correct injection technique.*

FDA Label Image

Diagramdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 02)

An instructional illustration showing a hand holding a prefilled syringe for subcutaneous injection aimed at the lower abdominal area, indicating the proper injection site for Enoxaparin Sodium injection.*

FDA Label Image

Diagram (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 01)

An instructional illustration showing a hand holding a pre-filled syringe labeled with a protective sleeve. An arrow indicates the direction of movement, likely demonstrating part of the preparation or administration process for an injection.*

FDA Label Image

Diagramdescription Automatically Generated (Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 00)

An instructional diagram showing a hand disposing of an Enoxaparin Sodium injection syringe by placing it needle-first into a labeled Sharps Disposal Container. The syringe's needle cover is visible, highlighting safe disposal practices for injection equipment.*

FDA Label Image

Enoxaparin Syringe Label 0.6ml (Enoxaparin Syringe Peel Back Lids Label Rev 1222 0.6ml.jpg)

Label for Enoxaparin Sodium Injection 60 mg/0.6 mL by BluePoint Laboratories, manufactured by Amphastar Pharmaceuticals. The label includes storage instructions, warnings, subcutaneous use indication, and safety device usage directions with illustrations. It also displays the NDC 68001-459-43 and a barcode.*

FDA Label Image

Enoxaparin Syringe Carton 0.3ml (Enoxaparin Syringe Carton Rev 1222 0.3ml.jpg)

Carton label for Enoxaparin Sodium Injection 100 mg/mL by BluePoint Laboratories. The label includes a dosing description for a single dose syringe with 30 mg/0.3 mL for subcutaneous use. Information about storage, usage, and warnings is printed along with the NDC code and barcode. The design features a white background with blue highlights.*

FDA Label Image

Enoxaparin Syringe Label 0.3ml (Enoxaparin Syringe Peel Back Lids Label Rev 1222 0.3ml.jpg)

Label for Enoxaparin Sodium Injection 30 mg/0.3 mL, a single dose prefilled syringe for subcutaneous use. The label includes manufacturer information for Amphastar Pharmaceuticals, Inc. for BluePoint Laboratories, usage warnings, storage instructions at 25°C, and instructions for safely removing the syringe peel. The label also shows the NDC 68001-457-43 and a barcode.*

FDA Label Image

Enoxaparin Syringe Carton 0.4ml (Enoxaparin Syringe Carton Rev 1222 0.4ml.jpg)

Packaging label for Enoxaparin Sodium Injection 40 mg/0.4 mL, a subcutaneous injection supplied in single-dose syringes. The label shows dosage and administration instructions, storage temperature guidelines, manufacturer BluePoint Laboratories, and a warning to keep out of reach of children. The label includes NDC 68001-458-42 and highlights the product is Rx only.*

FDA Label Image

Enoxaparin Syringe Label 0.4ml (Enoxaparin Syringe Peel Back Lids Label Rev 1222 0.4ml.jpg)

Label for Enoxaparin Sodium Injection 40 mg/0.4 mL, a subcutaneous single dose prefilled syringe with safety device. The label shows storage information, warnings to keep out of reach of children, manufacturer Amphastar Pharmaceuticals for BluePoint Laboratories, and instructions for syringe use. The NDC is 68001-458-43.*

FDA Label Image

Enoxaparin Syringe Carton 0.6ml (Enoxaparin Syringe Carton Rev 1222 0.6ml.jpg)

Packaging label for Enoxaparin Sodium Injection 60 mg/0.6 mL (equivalent to 100 mg/mL) in single dose syringes. Label indicates subcutaneous use, non-VA area, Rx only, and includes storage instructions. Manufactured by BluePoint Laboratories, Amphastar Pharmaceuticals. The label has a white background with orange and blue accents and includes barcode and warning information.*

FDA Label Image

Enoxaparin Syringe Carton 0.8ml (Enoxaparin Syringe Carton Rev 1222 0.8ml.jpg)

Carton label for Enoxaparin Sodium Injection 80 mg/0.8 mL single-dose syringes by BluePoint Laboratories. The label includes dosing and usage instructions, storage conditions, barcodes, warnings, and manufacturer information. The label design features orange and blue bands, with text emphasizing subcutaneous use and Rx only status.*

FDA Label Image

Enoxaparin Syringe Label 0.8ml (Enoxaparin Syringe Peel Back Lids Label Rev 1222 0.8ml.jpg)

Label for Enoxaparin Sodium Injection 80 mg/0.8 mL, a single dose prefilled syringe for subcutaneous use. The label includes manufacturer information (Amphastar Pharmaceuticals for BluePoint Laboratories), storage instructions, warnings, and illustrations on how to use the syringe safely. It displays the NDC 68001-460-43 and a barcode.*

FDA Label Image

Enoxaparin Syringe Carton 1ml (Enoxaparin Syringe Carton Rev 1222 1ml)

Carton label for Enoxaparin Sodium Injection, 100 mg/mL by BluePoint Laboratories. The package contains ten 1 mL single-dose syringes with automatic safety devices for subcutaneous use. Storage and administration instructions are included, with the product indicated as Rx only and for single-dose use.*

FDA Label Image

Enoxaparin Syringe Label 1ml (Enoxaparin Syringe Peel Back Lids Label Rev 1222 1.0ml.jpg)

Label for Enoxaparin Sodium Injection 100 mg/mL for subcutaneous use, manufactured by Amphastar Pharmaceuticals for BluePoint Laboratories. It includes usage warnings, storage instructions at 25°C (77°F), and dose type as a single-dose prefilled syringe with a safety device. The label features visual instructions for peeling the lid and warns against removing the syringe by pulling on the plunger. National Drug Code (NDC) 68001-461-43 is shown along with a barcode.*

FDA Label Image

Enoxaparin Syringe Carton 120mg (Enoxaparin Syringe Carton Rev 1222 120mg 0.8ml.jpg)

Packaging label for Enoxaparin Sodium Injection 120 mg/0.8 mL single dose syringes by BluePoint Laboratories. The label includes directions for subcutaneous use, dosage information, storage instructions, a barcode, and manufacturer details for Amphastar Pharmaceuticals, Inc. The package contains ten 0.8 mL single dose syringes with automatic safety devices.*

FDA Label Image

Enoxaparin Syringe Label 120mg_0.8mll (Enoxaparin Syringe Peel Back Lids Label Rev 1222 120mg 0.8ml.jpg)

Label for Enoxaparin Sodium Injection 120 mg/0.8 mL, indicating it is a single dose prefilled syringe with a safety device for subcutaneous use. The label includes storage instructions, warnings, manufacturer information (Amphastar Pharmaceuticals for BluePoint Laboratories), and usage illustrations demonstrating syringe handling. The label also features barcode and NDC number 68001-462-43.*

FDA Label Image

Enoxaparin Syringe Carton 150mg (Enoxaparin Syringe Carton Rev 1222 150mg 1ml)

The packaging label for Enoxaparin Sodium Injection 150 mg/mL features a mostly white and blue color scheme. It is labeled for subcutaneous use only and indicates single dose syringes with automatic safety devices. The label includes storage instructions, manufacturer information for Amphastar Pharmaceuticals, and the labeler BluePoint Laboratories. The NDC number 68001-463-42 is visible on the label.*

FDA Label Image

Enoxaparin Syringe Label 150mg (Enoxaparin Syringe Peel Back Lids Label Rev 1222 150mg 1.0ml.jpg)

Two packaging labels for Enoxaparin Sodium Injection, each showing a strength of 150 mg/mL. The labels state the product is for subcutaneous use and prescription only, manufactured by Amphastar Pharmaceuticals for BluePoint Laboratories. They include handling instructions with illustrations on peeling the lid and not pulling on the syringe plunger. Each label displays the NDC number 68001-463-43 and a barcode.*

FDA Label Image

Enoxaparin Vial Carton (Enox Vial Carton)

Packaging label for Enoxaparin Sodium Injection, USP 300 mg/3 mL [100 mg/mL], multiple-dose vial by BluePoint Laboratories. The label includes dosage and administration instructions for subcutaneous or intravenous injection, storage conditions (20° to 25°C), and a warning to keep out of reach of children. The vial size is one 3 mL vial, and the label mentions manufacturing by Amneal Pharmaceuticals for BluePoint Laboratories.*

FDA Label Image

Enoxaparin Sodium Injection Vial Label (Image 08)

Label for Enoxaparin Sodium Injection, USP 300 mg/3 mL (100 mg/mL) multiple dose vial. The label states the drug is for subcutaneous or intravenous injection and is manufactured for BluePoint Laboratories by Amphastar Pharmaceuticals, Inc. Storage instructions specify 20° to 25°C (68° to 77°F) with a 28-day usage limit after first use. NDC 68001-464-41 is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.